Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma

CONCLUSION: Our exploratory study revealed that the response rate of second-line chemotherapy regimens for patients with synovial sarcoma was 9.4%. Therefore, there is an urgent need to develop more active therapeutic regimens for synovial sarcomas.PMID:35405680 | DOI:10.1159/000524500

Source: Oncology - April 11, 2022 Category: Cancer & Oncology Authors: Yuki Kojima Tatsunori Shimoi Takuji Seo Shu Yazaki Toshihiro Okuya Yohei Ohtake Hitomi S Okuma Akihiko Shimomura Tadaaki Nishikawa Maki Tanioka Kazuki Sudo Emi Noguchi Kenji Tamura Akihiko Yoshida Shintaro Iwata Eisuke Kobayashi Akira Kawai Yasuhiro Fujiw Source Type: research